Inventor · disambiguated record
Feng Tian
Also filed as: TIAN FENG
42 granted patents·22 pending applications·422 citations·filing 2005–2024
98Inventor score
Top patents by PatentIndex Score
64 records- 0198US8053560B2Modified human plasma polypeptide or Fc scaffolds and their usesAMBRX INC·Filed 2007·Granted Nov 8, 2011·40 cites·5 claims
- 0298US7919591B2Modified human plasma polypeptide or Fc scaffolds and their usesAMBRX INC·Filed 2007·Granted Apr 5, 2011·41 cites·1 claims
- 0397US7632924B2Antigen-binding polypeptides and their usesAMBRX INC·Filed 2005·Granted Dec 15, 2009·79 cites·8 claims
- 0496US8618257B2Modified human plasma polypeptide or Fc scaffolds and their usesSHEFFER JOSEPH·Filed 2007·Granted Dec 31, 2013·32 cites·4 claims
- 0596US8420792B2Suppressor tRNA transcription in vertebrate cellsTIAN FENG·Filed 2007·Granted Apr 16, 2013·32 cites·46 claims
- 0696US8022186B2Modified human plasma polypeptide or Fc scaffolds and their usesAMBRX INC·Filed 2007·Granted Sep 20, 2011·20 cites·5 claims
- 0796US7888533B2Accelerants for the modification of non-natural amino acids and non-natural amino acid polypeptidesAMBRX INC·Filed 2007·Granted Feb 15, 2011·35 cites·10 claims
- 0895US7468458B2Accelerants for the modification of non-natural amino acids and non-natural amino acid polypeptidesAMBRX INC·Filed 2007·Granted Dec 23, 2008·24 cites·26 claims
- 0992US8569233B2Modified animal erythropoietin polypeptides and their usesTIAN FENG·Filed 2012·Granted Oct 29, 2013·17 cites·15 claims
- 1092US8278418B2Modified animal erythropoietin polypeptides and their usesTIAN FENG·Filed 2009·Granted Oct 2, 2012·21 cites·12 claims
- 1192US7632823B2Compositions of tRNA and uses thereofAMBRX INC·Filed 2005·Granted Dec 15, 2009·19 cites·43 claims
- 1291US8071809B2Accelerants for the modification of non-natural amino acids and non-natural amino acid polypeptidesTIAN FENG·Filed 2010·Granted Dec 6, 2011·14 cites·18 claims
- 1388US10227587B2Method for constructing a plasma DNA sequencing libraryBERRY GENOMICS CO LTD·Filed 2016·Granted Mar 12, 2019·8 cites·11 claims
- 1486US9175083B2Antigen-binding polypeptides and their usesCHO HO SUNG·Filed 2007·Granted Nov 3, 2015·6 cites·1 claims
- 1585US9133495B2Hybrid suppressor tRNA for vertebrate cellsTIAN FENG·Filed 2007·Granted Sep 15, 2015·4 cites·26 claims
- 1684US8946148B2Modified insulin polypeptides and their usesMIAO ZHENWEI·Filed 2008·Granted Feb 3, 2015·6 cites·3 claims
- 1783US11661596B2Targeted RNA editing by leveraging endogenous ADAR using engineered RNAsUNIV BEIJING·Filed 2022·Granted May 30, 2023·1 cites·25 claims
- 1882US9644014B2Modified animal erythropoietin polypeptides and their usesAMBRX INC·Filed 2015·Granted May 9, 2017·3 cites·12 claims
- 1982US9488660B2Methods and compositions comprising non-natural amino acidsMIAO ZHENWEI·Filed 2010·Granted Nov 8, 2016·3 cites·2 claims
- 2082US9121024B2Non-natural amino acid replication-dependent microorganisms and vaccinesTIAN FENG·Filed 2009·Granted Sep 1, 2015·4 cites·8 claims
- 2179US8940927B2Activators of glucokinaseTIAN FENG·Filed 2011·Granted Jan 27, 2015·4 cites·31 claims
- 2278US9121025B2Non-natural amino acid replication-dependent microorganisms and vaccinesAMBRX INC·Filed 2013·Granted Sep 1, 2015·2 cites·10 claims
- 2377US11851662B2Methods and compositions for promoting non-natural amino acid-containing protein productionAMBRX INC·Filed 2018·Granted Dec 26, 2023·1 cites·24 claims
- 2477US9156899B2Modified animal erythropoietin polypeptides and their usesAMBRX INC·Filed 2013·Granted Oct 13, 2015·2 cites·11 claims
- 2577US9074010B2Modified human plasma polypeptide or Fc scaffolds and their usesSHEFFER JOSEPH·Filed 2011·Granted Jul 7, 2015·1 cites·4 claims
- 2675US10800856B2Prostate-specific membrane antigen antibody drug conjugatesAMBRX INC·Filed 2013·Granted Oct 13, 2020·2 cites·5 claims
- 2774US10428333B2Non-natural amino acid replication-dependent microorganisms and vaccinesAMBRX INC·Filed 2013·Granted Oct 1, 2019·1 cites·11 claims
- 2871US2023365962A1Targeted rna editing by leveraging endogenous adar using engineered rnasUNIV BEIJING·Filed 2023·Application pending·0 cites
- 2970US2024391974A1Interleukin-2 polypeptide conjugates and their usesAMBRX INC·Filed 2024·Application pending·0 cites
- 3070US2024350835A1Humanized anti-prostate -specific membrane antigen (psma) antibody drug conjugatesAMBRX INC·Filed 2024·Application pending·0 cites
- 3166US2024239889A1Anti-cd3-folate conjugates and their usesAMBRX INC·Filed 2023·Application pending·0 cites
- 3266US2014296487A1Modified Human Plasma Polypeptide or Fc Scaffolds and Their UsesSHEFFER JOSEPH·Filed 2013·Application pending·0 cites
- 3365US12059473B2Humanized anti-prostate -specific membrane antigen (PSMA) antibody drug conjugatesAMBRX INC·Filed 2019·Granted Aug 13, 2024·0 cites·22 claims
- 3465US12049485B2Interleukin-2 polypeptide conjugates and their usesAMBRX INC·Filed 2019·Granted Jul 30, 2024·0 cites·16 claims
- 3565US2024024368A1Compositions and methods for neuroprotection and/or neuroregenerationCHILDRENS MEDICAL CT CORP·Filed 2023·Application pending·0 cites
- 3664US2023310473A1Method for treating obesity and/or hypertensionTHE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIV·Filed 2023·Application pending·0 cites
- 3762US2010087677A1Compositions of tRNA and Uses ThereofAMBRX INC·Filed 2009·Application pending·0 cites
- 3861US2011207914A1Modified Human Plasma Polypeptide or Fc Scaffolds and Their UsesAMBRX INC·Filed 2011·Application pending·0 cites
- 3960US2009137736A1Accelerants for the Modification of Non-Natural Amino Acids and Non-Natural Amino Acid PolypeptidesAMBRX INC·Filed 2006·Application pending·0 cites
- 4060US2012041180A1Modified Human Plasma Polypeptide or Fc Scaffolds and Their UsesSHEFFER JOSEPH·Filed 2011·Application pending·0 cites
- 4159US9522926B2Activators of glucokinaseMETABASIS THERAPEUTICS INC·Filed 2014·Granted Dec 20, 2016·0 cites·56 claims
- 4258US8367588B2Selective posttranslational modification of phage-displayed polypeptidesSCRIPPS RESEARCH INST·Filed 2006·Granted Feb 5, 2013·0 cites·8 claims
- 4358US2022243194A1Targeted rna editing by leveraging endogenous adar using engineered rnasUNIV BEIJING·Filed 2020·Application pending·0 cites
- 4458US2022033518A1Prostate-specific membrane antigen antibody drug conjugatesAMBRX INC·Filed 2020·Application pending·0 cites
- 4557US9868972B2Hybrid suppressor tRNA for vertebrate cellsAMBRX INC·Filed 2015·Granted Jan 16, 2018·0 cites·7 claims
- 4656US2014045259A1Suppressor tRNA Transcription in Vertebrate CellsAMBRX INC·Filed 2013·Application pending·0 cites
- 4755US11123452B2Alkyl chitosan-graphene oxide composite sponge and preparation method and application thereofINSTITUTE OF MEDICAL SUPPORT TECH ACADEMY OF SYSTEM ENGINEERING ACADEMY OF MILITARY SCIENCE·Filed 2019·Granted Sep 21, 2021·0 cites·12 claims
- 4855US2025161471A1Anti-her2 antibody-drug conjugates and uses thereofTIAN FENG·Filed 2022·Application pending·0 cites
- 4954US2009018029A1Methods and Compositions Comprising Non-Natural Amino AcidsAMBRX INC·Filed 2006·Application pending·0 cites
- 5054US2023226152A1Interleukin-2 polypeptide conjugates and methods of use thereofAMBRX INC·Filed 2022·Application pending·0 cites
Showing the top 50 of 64 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Feng Tian files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →